← Back
Data updated: Mar 29, 2026
AMTA
CardiovascularNeurologyImmunology
Generics
AMTA is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology.
2020
Since
5
Drugs
-
Trials
95
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 25%
1 drugs
Neurology 25%
1 drugs
Immunology 25%
1 drugs
Gastroenterology 25%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Neurology
BAUSCH specialty
Immunology, Cardiovascular, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Immunology, Gastroenterology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular, Immunology
Active (3)
Discontinued (2)
Company Info
- First Approval
- 2020-01-06
- Latest
- 2026-01-18
- Applications
- 5